...
首页> 外文期刊>The American Journal of Tropical Medicine and Hygiene >Successful Antiparasitic Treatment for Cysticercosis Is Associated with a Fast and Marked Reduction of Circulating Antigen Levels in a Naturally Infected Pig Model
【24h】

Successful Antiparasitic Treatment for Cysticercosis Is Associated with a Fast and Marked Reduction of Circulating Antigen Levels in a Naturally Infected Pig Model

机译:成功的抗寄生虫病治疗与自然感染的猪模型中循环抗原水平的快速显着降低有关。

获取原文
获取原文并翻译 | 示例

摘要

Taenia solium cysticercosis is a common parasitic infection of humans and pigs. We evaluated the posttreatment evolution of circulating parasite-specific antigen titers in 693 consecutive blood samples from 50 naturally infected cysticercotic pigs, which received different regimes of antiparasitic drugs (N = 39, 7 groups), prednisone (N = 5), or controls (N = 6). Samples were collected from baseline to week 10 after treatment, when pigs were euthanized and carefully dissected at necropsy. Antigen levels decreased proportionally to the efficacy of treatment and correlated with the remaining viable cysts at necropsy (Pearson's p = 0.67, P = 0.000). A decrease of 5 times in antigen levels (logarithmic scale) compared with baseline was found in 20/26 pigs free of cysts at necropsy, compared with 1/24 of those who had persisting viable cysts (odds ratio [OR] = 76.7, 95% confidence interval [CI] = 8.1-3308.6, P < 0.001). Antigen monitoring reflects the course of infection in the pig. If a similar correlation exists in infected humans, this assay may provide a minimally invasive and easy monitoring assay to assess disease evolution and efficacy of antiparasitic treatment in human neurocysticercosis.
机译:猪带so虫囊尾rc病是人和猪的常见寄生虫感染。我们评估了50例自然感染的囊尾rc猪的693个连续血液样本中循环寄生虫特异性抗原滴度的治疗后演变,这些猪接受了不同方案的抗寄生虫药物(N = 39,7组),泼尼松(N = 5)或对照组( N = 6)。从基线到治疗后第10周收集样品,对猪实施安乐死并在尸检时仔细解剖。抗原水平与治疗效果成正比降低,并且与尸检时剩余的存活囊肿相关(Pearson's p = 0.67,P = 0.000)。尸检时发现无囊肿的20/26头猪的抗原水平(对数标度)比基线降低了5倍,而有存活囊肿的猪的抗原水平(对数比[OR] = 76.7,95)为1/24 %置信区间[CI] = 8.1-3308.6,P <0.001)。抗原监测反映了猪的感染过程。如果在感染的人类中存在相似的相关性,则该测定法可提供一种微创且易于监测的测定法,以评估疾病的进展和人类神经囊虫病抗寄生虫治疗的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号